Postural Stability in Parkinson’s Disease Patients Is Improved after Stochastic Resonance Therapy

Table 1

Demographics and clinical scores of patients at baseline.

	Sham ()	Experimental ()
Male/female	17/9	19/11
Age (y)	67,92 8,78	66,10 8,28
Disease duration (y)	6,96 5,15	7,03 6,48
Hoehn and Yahr stage	2,81 0,80	2,60 0,81
I,	1	3
II,	8	9
III,	12	15
IV,	5	3
UPDRS	25,00 10,46	25,13 13,14
Pull-test	1,50 1,17	1,37 0,89
TUG (s)	11,96 10,47	11,03 9,92
Tinetti score	21,85 7,32	23,17 4,77
8MW (s)	6,67 3,22	6,67 2,58
Fallers/nonfallers, (%)	13 (50,00)	18 (60,00)
Levodopa, (%)	23 (88,46)	24 (80,00)
Levodopa (mg/day)	484,62 311,37	320,83 226,67
Dopamine agonist, (%)	18 (69,23)	25 (83,33)
MAOB inhibitor, (%)	16 (61,53)	16 (50)
Anticholinergic, (%)	1 (3,84)	0 (0)
Nootropic drugs,    (%)	4 (15,38)	1 (3,33)

Comparing control and disease group no statistically significant differences were detectable.